The global vulvovaginal candidiasis treatment market is currently valued at USD 1035 million in 2023 and is anticipated to expand at a CAGR of 4.5%. Owing to the technological advances in healthcare ...

The World Health Organization (WHO) today published its first-ever reports addressing the critical lack of medicines and ...

A WOMAN was left with dark and smelly discharge coming from her vagina after taking hair supplements. The 64-year-old began ...

A yeast infection, also known as candidiasis, is a fungal infection that is caused by an overgrowth of yeast. It can be ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

In a nutshell Climate change is accelerating fungal threats by helping pathogens evolve heat tolerance, spread to new regions, and infect hosts—including humans—who were once protected by body ...

To combat long-overlooked fungal pathogens, researchers and regulators must embrace innovative science and policy.

Explore holistic approaches to treating the atopic triad in children—eczema, asthma, and allergies—with naturopathic ...

We’re on the precipice of sandal weather, whether your toes are ready or not. But if a particularly persistent and unsightly ...

Fungal infections in India are rising, with growing resistance to treatment. Learn about common types, causes, drug ...

COOLOGICS' initiation of multi-center clinical trials is a step toward obtaining FDA approval for Vlisse. The company is set to meaningfully impact women's health by offering a drug-free solution for ...